Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a251ae79dd7a008d95010b238c6aa1f8 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-308 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-035 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-045 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2008-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25f375bd3447ed6c4452aa061c9c335e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3644e66da2d6dbb89e8856b69f8512df http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7eb5d05ff55d765eb08cafe3ba58b44a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1affea8e9f9c1579e90ded810fa8c101 |
publicationDate |
2009-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20090090432-A |
titleOfInvention |
Pharmaceutical composition for liver cancer treatment containing kenodeoxycholic acid derivative as an active ingredient |
abstract |
The present invention relates to a pharmaceutical composition for treating liver cancer containing a kenodeoxycholine acid derivative represented by the following formula (1) as an active ingredient, and more specifically, such a kenodeoxycholine acid derivative inhibits cell proliferation and at the same time apoptosis. By inducing it can be very useful for the prevention and treatment of liver cancer.n n n [Formula 1] |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022171040-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021023100-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112341514-A |
priorityDate |
2008-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |